Marked expression of plasma brain natriuretic peptide is a special feature of hypertrophic obstructive cardiomyopathy
- 1 November 1996
- journal article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 28 (5) , 1234-1242
- https://doi.org/10.1016/s0735-1097(96)00277-x
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Quantitative hemodynamics by Doppler echocardiography: A noninvasive alternative to cardiac catheterizationProgress in Cardiovascular Diseases, 1994
- Expression of brain natriuretic peptide gene in human heart. Production in the ventricle.Hypertension, 1991
- Isolation and sequence determination of human brain natriuretic peptide in human atriumFEBS Letters, 1990
- Continuous-wave Doppler echocardiographic assessment of severity of calcific aortic stenosis: a simultaneous Doppler-catheter correlative study in 100 adult patients.Circulation, 1985
- Relation between marked changes in left ventricular outflow tract gradient and disease progression in hypertrophic cardiomyopathyThe American Journal of Cardiology, 1984
- Quantification of pressure gradients across stenotic valves by Doppler ultrasoundJournal of the American College of Cardiology, 1983
- Myocardial fiber diameter and regional distribution in the ventricular wall of normal adult hearts, hypertensive hearts and hearts with hypertrophic cardiomyopathy.Circulation, 1983
- Hypertrophic nonobstructive cardiomyopathy: A precise assessment of hemodynamic characteristics and clinical implicationsThe American Journal of Cardiology, 1982
- Report of the WHO/ISFC task force on the definition and classification of cardiomyopathies.Heart, 1980
- Hypertrophic cardiomyopathy: Subclassification by M mode echocardiographyThe American Journal of Cardiology, 1980